Published Date:Mar.2021
Industry:Chemical & Material
Pages:100 Table Number:124
Single User Price:¥3650.00
Enterprise User Price:¥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Interferon Beta-1a market in this environment. In terms of revenue, this research report indicated that the global Interferon Beta-1a market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Interferon Beta-1a industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Teva aims at producing XX K Units Interferon Beta-1a in 2020, with XX % production to take place in global market, Biogen Idec accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Interferon Beta-1a Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Interferon Beta-1a Market? Teva Biogen Idec Merck KGaA Novartis Bayer HealthCare Acorda Therapeutics Questcor Pharmaceuticals Sanofi ... Major Type of Interferon Beta-1a Covered in XYZResearch report: Prefilled Syringe Powder Form Application Segments Covered in XYZResearch Market Hospital Drugs Store Other For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Interferon Beta-1a Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Prefilled Syringe -Product Introduction and Major Manufacturers 1.1.2 Powder Form -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Interferon Beta-1a Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Interferon Beta-1a Market 3.1.1 Top Companies leading Interferon Beta-1a Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Interferon Beta-1a Market 3.2.1 Top Companies leading Interferon Beta-1a Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Interferon Beta-1a Market 3.3.1 Top Companies leading Interferon Beta-1a Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Interferon Beta-1a Market 3.4.1 Top Companies leading Interferon Beta-1a Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Interferon Beta-1a Market 3.5.1 Top Companies leading Interferon Beta-1a Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Interferon Beta-1a Market 3.6.1 Top Companies leading Interferon Beta-1a Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Interferon Beta-1a Market 3.7.1 Top Companies leading Interferon Beta-1a Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Interferon Beta-1a Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Interferon Beta-1a Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Interferon Beta-1a Sales and Growth Rate (2021-2027) 5.2 Global Interferon Beta-1a Sales Value and Growth Rate (2021-2027) 6 Interferon Beta-1a Competitive Analysis 6.1 Teva 6.1.1 Teva Company Profiles 6.1.2 Teva Product Introduction 6.1.3 Teva Interferon Beta-1a Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Biogen Idec 6.2.1 Biogen Idec Company Profiles 6.2.2 Biogen Idec Product Introduction 6.2.3 Biogen Idec Interferon Beta-1a Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Merck KGaA 6.3.1 Merck KGaA Company Profiles 6.3.2 Merck KGaA Product Introduction 6.3.3 Merck KGaA Interferon Beta-1a Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Novartis 6.4.1 Novartis Company Profiles 6.4.2 Novartis Product Introduction 6.4.3 Novartis Interferon Beta-1a Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Bayer HealthCare 6.5.1 Bayer HealthCare Company Profiles 6.5.2 Bayer HealthCare Product Introduction 6.5.3 Bayer HealthCare Interferon Beta-1a Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Acorda Therapeutics 6.6.1 Acorda Therapeutics Company Profiles 6.6.2 Acorda Therapeutics Product Introduction 6.6.3 Acorda Therapeutics Interferon Beta-1a Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Questcor Pharmaceuticals 6.7.1 Questcor Pharmaceuticals Company Profiles 6.7.2 Questcor Pharmaceuticals Product Introduction 6.7.3 Questcor Pharmaceuticals Interferon Beta-1a Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Sanofi 6.8.1 Sanofi Company Profiles 6.8.2 Sanofi Product Introduction 6.8.3 Sanofi Interferon Beta-1a Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Interferon Beta-1a Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Interferon Beta-1a Sales (K Unit) by Type (2026-2027) Figure Global Interferon Beta-1a Sales (K Unit) and Growth Rate (2026-2027) Figure Global Interferon Beta-1a Sales Market Share (%) by Type (2019 -2020) Table Global Interferon Beta-1a Sales Value (Million USD) by Type (2026-2027) Figure Global Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Interferon Beta-1a Sales Value Market Share (%) by Type (2019-2020) Table Global Interferon Beta-1a Sales (K Unit) by Application (2026-2027) Table China Interferon Beta-1a Sales (K Unit) of Major Company (2016-2021) Table China Interferon Beta-1a Sales Market Share of Major Company (2016-2021) Table China Interferon Beta-1a Sales Value (Million USD) of Major Company (2016-2021) Figure China Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2016-2021) Table China Interferon Beta-1a Sales Value Share of Major Company (2016-2021) Table China Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) Table China Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure China Interferon Beta-1a Sales (Unit) by Type (2026-2027) Table EU Interferon Beta-1a Sales (K Unit) of Major Company (2016-2021) Table EU Interferon Beta-1a Sales Market Share of Major Company (2016-2021) Table EU Interferon Beta-1a Sales Value (Million USD) of Major Company (2016-2021) Figure EU Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Interferon Beta-1a Sales Value Share of Major Company (2016-2021) Table EU Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) Table EU Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure EU Interferon Beta-1a Sales (Unit) by Type (2026-2027) Table USA Interferon Beta-1a Sales (K Unit) of Major Company (2016-2021) Table USA Interferon Beta-1a Sales Market Share of Major Company (2016-2021) Table USA Interferon Beta-1a Sales Value (Million USD) of Major Company (2016-2021) Figure USA Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Interferon Beta-1a Sales Value Share of Major Company (2016-2021) Table USA Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) Table USA Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure USA Interferon Beta-1a Sales (Unit) by Type (2026-2027) Table Japan Interferon Beta-1a Sales (K Unit) of Major Company (2016-2021) Table Japan Interferon Beta-1a Sales Market Share of Major Company (2016-2021) Table Japan Interferon Beta-1a Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Interferon Beta-1a Sales Value Share of Major Company (2016-2021) Table Japan Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) Table Japan Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure Japan Interferon Beta-1a Sales (Unit) by Type (2026-2027) Table India Interferon Beta-1a Sales (K Unit) of Major Company (2016-2021) Table India Interferon Beta-1a Sales Market Share of Major Company (2016-2021) Table India Interferon Beta-1a Sales Value (Million USD) of Major Company (2016-2021) Figure India Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2016-2021) Table India Interferon Beta-1a Sales Value Share of Major Company (2016-2021) Table India Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) Table India Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure India Interferon Beta-1a Sales (Unit) by Type (2026-2027) Table Southeast Asia Interferon Beta-1a Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Interferon Beta-1a Sales Market Share of Major Company (2016-2021) Table Southeast Asia Interferon Beta-1a Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Interferon Beta-1a Sales Value Share of Major Company (2016-2021) Table Southeast Asia Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure Southeast Asia Interferon Beta-1a Sales (Unit) by Type (2026-2027) Table South America Interferon Beta-1a Sales (K Unit) of Major Company (2016-2021) Table South America Interferon Beta-1a Sales Market Share of Major Company (2016-2021) Table South America Interferon Beta-1a Sales Value (Million USD) of Major Company (2016-2021) Figure South America Interferon Beta-1a Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Interferon Beta-1a Sales Value Share of Major Company (2016-2021) Table South America Interferon Beta-1a Price (USD/Unit), by Type (2019-2020) Table South America Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure South America Interferon Beta-1a Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Interferon Beta-1a Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Interferon Beta-1a Figure Cost Structure of Interferon Beta-1a in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Interferon Beta-1a Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Interferon Beta-1a Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Teva Profiles Table Teva Interferon Beta-1a Product Introduction Table Teva Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Teva SWOT Analysis Table Biogen Idec Profiles Table Biogen Idec Interferon Beta-1a Product Introduction Table Biogen Idec Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Biogen Idec SWOT Analysis Table Merck KGaA Profiles Table Merck KGaA Interferon Beta-1a Product Introduction Table Merck KGaA Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Merck KGaA SWOT Analysis Table Novartis Profiles Table Novartis Interferon Beta-1a Product Introduction Table Novartis Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Novartis SWOT Analysis Table Bayer HealthCare Profiles Table Bayer HealthCare Interferon Beta-1a Product Introduction Table Bayer HealthCare Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Bayer HealthCare SWOT Analysis Table Acorda Therapeutics Profiles Table Acorda Therapeutics Interferon Beta-1a Product Introduction Table Acorda Therapeutics Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Acorda Therapeutics SWOT Analysis Table Questcor Pharmaceuticals Profiles Table Questcor Pharmaceuticals Interferon Beta-1a Product Introduction Table Questcor Pharmaceuticals Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Questcor Pharmaceuticals SWOT Analysis Table Sanofi Profiles Table Sanofi Interferon Beta-1a Product Introduction Table Sanofi Interferon Beta-1a Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)